NASDAQ (usa) | 6715.56 | -12.11 | -0.18% | |
FTSE 100 (london) | 7487.96 | -5.12 | -0.07% | |
DAX (german) | 13465.51 | 235.94 | 1.78% | |
NIKKEI 225 (japan) | 22420.08 | 408.47 | 1.86% | |
Hang - Seng (hong kong) | 28594.06 | 348.52 | 1.23% |
NIFTY - 50 (india) | ||||
Straits Times (singapore) | 3391.61 | 17.53 | 0.52% | |
KOSPI (korea) | 2556.47 | 33.04 | 1.31% | |
All Ordinaries (australia) | 6005.30 | 28.90 | 0.48% | |
BOVESPA (brazil) | 74092.76 | -215.73 | -0.29% |
Huapont Life Sciences Co. Ltd (SHE: 002004)
002004 Technical Analysis
5
As on 27th Jan 2025 002004 STOCK Price closed @ 3.85 and we RECOMMEND Strong Sell for LONG-TERM with Stoploss of 4.62 & Strong Sell for SHORT-TERM with Stoploss of 5.02 we also expect STOCK to react on Following IMPORTANT LEVELS. |
002004STOCK Price
Open | 3.85 | Change | Price | % |
High | 3.92 | 1 Day | 0.01 | 0.26 |
Low | 3.85 | 1 Week | -0.48 | -11.09 |
Close | 3.85 | 1 Month | -0.93 | -19.46 |
Volume | 33710900 | 1 Year | -1.34 | -25.82 |
52 Week High 5.23 | 52 Week Low 3.73 |
SHE China Most Active Stocks
002131 | 3.64 | -1.62% |
300059 | 22.94 | -4.77% |
000882 | 3.38 | -9.87% |
000564 | 2.59 | -5.47% |
000981 | 2.03 | -6.02% |
300170 | 19.59 | 0.15% |
002031 | 6.14 | -9.97% |
002122 | 3.97 | -7.46% |
000725 | 4.46 | -0.45% |
002354 | 6.10 | 4.45% |
SHE China Top Gainers Stocks
SHE China Top Losers Stocks
002004 Daily Charts |
002004 Intraday Charts |
Whats New @ Bazaartrend |
002004 Free Analysis |
|
002004 Important Levels Intraday
RESISTANCE | 3.98 |
RESISTANCE | 3.94 |
RESISTANCE | 3.91 |
RESISTANCE | 3.89 |
SUPPORT | 3.81 |
SUPPORT | 3.79 |
SUPPORT | 3.76 |
SUPPORT | 3.72 |
002004 Forecast February 2025
4th UP Forecast | 4.7 |
3rd UP Forecast | 4.43 |
2nd UP Forecast | 4.26 |
1st UP Forecast | 4.09 |
1st DOWN Forecast | 3.61 |
2nd DOWN Forecast | 3.44 |
3rd DOWN Forecast | 3.27 |
4th DOWN Forecast | 3 |
002004 Weekly Forecast
4th UP Forecast | 4.35 |
3rd UP Forecast | 4.19 |
2nd UP Forecast | 4.09 |
1st UP Forecast | 3.99 |
1st DOWN Forecast | 3.71 |
2nd DOWN Forecast | 3.61 |
3rd DOWN Forecast | 3.51 |
4th DOWN Forecast | 3.35 |
002004 Forecast2025
4th UP Forecast | 6.95 |
3rd UP Forecast | 5.96 |
2nd UP Forecast | 5.34 |
1st UP Forecast | 4.73 |
1st DOWN Forecast | 2.97 |
2nd DOWN Forecast | 2.36 |
3rd DOWN Forecast | 1.74 |
4th DOWN Forecast | 0.75 |
Huapont Life Sciences Co. Ltd ( SHE China Symbol : 002004 )
Sector : Healthcare And Other Stocks in Same Sector
Sector : Healthcare And Other Stocks in Same Sector
002004 Other Details
Segment | EQ | |
Market Capital | 12117109760.00 | |
Sector | Healthcare | |
Industry | Drug Manufacturers-Specialty & Generic | |
Offical website | > echo $website ; ?> |
002004 Address
002004 Latest News
002004 Business Profile
Huapont Life Sciences Co., Ltd. engages in the pharmaceutical and agrochemical businesses in China and internationally. The company is involved in the production and sale of pharmaceutical preparations and intermediates. It also offers medicines for skin, tuberculosis, anti-infection, respiratory, anti-tumor, and ophthalmology, as well as health management products. In addition, the company provides pesticide technical, intermediate and preparation products, and GLP registration technical services. The company was formerly known as Huapont-Nutrichem Co., Ltd. and changed its name to Huapont Life Sciences Co., Ltd. in September 2015. Huapont Life Sciences Co., Ltd. was founded in 2001 and is based in Chongqing, China. Address: 69 Renhe Xingguang Avenue, Chongqing, China, 401121
© 2005-2023 BazaarTrend.com All rights reserved.
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service